Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × INDUSTRY × Sodium Chloride × Clear all

Phase

Status

Completed 14 Terminated 12 Active not recruiting 2 Withdrawn 1 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 17 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Locally Advanced Cervical Cancer 1

Interventions

pembrolizumab 245 Carboplatin 172 Injections 137 Paclitaxel 124 Gemcitabine 118 Bevacizumab 116 Cisplatin 113 Pemetrexed 82 Docetaxel 81 Cyclophosphamide 67 Capecitabine 67 Fluorouracil 63 Oxaliplatin 60 Nivolumab 57 Fulvestrant 55 Cetuximab 53 130-nm albumin-bound paclitaxel 50 Leucovorin 48 fludarabine 46 Dexamethasone 45 atezolizumab 42 Rituximab 41 venetoclax 37 Drug Therapy 36 toripalimab 35 enzalutamide 34 durvalumab 32 Irinotecan 32 Lenalidomide 31 Doxorubicin 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06079671 2026-04-02

eVOLVECervical

AstraZeneca

Phase 3 Recruiting

Locally Advanced Cervical Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡